We came across a bullish thesis on Bristol-Myers Squibb Company on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company's share was trading at $49 recently. BMY’s trailing and forward P/E were 16.6 and 8 respectively according to Yahoo Finance.
[caption id="attachment_565116" align="aligncenter" width="750"]Bristol-Myers Squibb Co. (NYSE: BMY) appears modestly undervalued following its recent earnings release, with valuation work suggesting the stock trades at about...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.